Literature DB >> 7530337

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

S T Ju1, D J Panka, H Cui, R Ettinger, M el-Khatib, D H Sherr, B Z Stanger, A Marshak-Rothstein.   

Abstract

Receptor crosslinking of T-cell hybridomas induces cell activation followed by apoptosis. This activation-induced cell death requires de novo synthesis of RNA and proteins, but the actual gene products that provide the death signal have not been identified. We show here that receptor crosslinking induces Fas ligand and upregulates Fas, and that the ensuing engagement of Fas by Fas ligand activates the cell-death programme. Cell death, but not activation, can be selectively prevented by a soluble Fas-immunoglobulin fusion protein. Thus, Fas and Fas ligand are the death-gene products, and their interaction accounts for the molecular mechanism of activation-induced T-cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530337     DOI: 10.1038/373444a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  347 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  Cell subpopulations in failed human corneal grafts.

Authors:  L Kuffová; V Holán; L Lumsden; J V Forrester; M Filipec
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

3.  Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge.

Authors:  S S Cohen; C Li; L Ding; Y Cao; A B Pardee; E M Shevach; D I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.

Authors:  C S Verbeke; U Wenthe; W F Bergler; H Zentgraf
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 6.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

7.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.

Authors:  T H Holmström; I Schmitz; T S Söderström; M Poukkula; V L Johnson; S C Chow; P H Krammer; J E Eriksson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

8.  CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

Authors:  M F Callan; C Fazou; H Yang; T Rostron; K Poon; C Hatton; A J McMichael
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.

Authors:  K Kemp; B D Akanmori; V Adabayeri; B Q Goka; J A L Kurtzhals; C Behr; L Hviid
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

10.  Activated T lymphocytes disappear from circulation during endotoxemia in humans.

Authors:  K S Krabbe; H Bruunsgaard; J Qvist; L Fonsmark; K Møller; C M Hansen; P Skinhøj; B K Pedersen
Journal:  Clin Diagn Lab Immunol       Date:  2002-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.